Nicholas I. Fleming

2.6k total citations · 1 hit paper
14 papers, 1.5k citations indexed

About

Nicholas I. Fleming is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Nicholas I. Fleming has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Nicholas I. Fleming's work include Genetic factors in colorectal cancer (3 papers), Cancer Genomics and Diagnostics (3 papers) and TGF-β signaling in diseases (2 papers). Nicholas I. Fleming is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), Cancer Genomics and Diagnostics (3 papers) and TGF-β signaling in diseases (2 papers). Nicholas I. Fleming collaborates with scholars based in Australia, New Zealand and United States. Nicholas I. Fleming's co-authors include Nada Al Tassan, Jeremy P. Cheadle, Angela Hodges, Nikolas H. Chmiel, Alison L. Livingston, Geraint T. Williams, Julian R. Sampson, Julie Maynard, D. Rhodri Davies and Sheila S. David and has published in prestigious journals such as Nature Genetics, PLoS ONE and Neurology.

In The Last Decade

Nicholas I. Fleming

13 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors

2002 980 citations Nada Al Tassan, Nikolas H. Chmiel et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas I. Fleming Australia	9	727	692	556	408	234	14	1.5k
Liesbeth Spruijt Netherlands	23	183 0.3×	1.0k 1.5×	195 0.4×	222 0.5×	620 2.6×	43	1.6k
Michael O. Woods Canada	20	525 0.7×	535 0.8×	418 0.8×	265 0.6×	557 2.4×	37	1.3k
Kaiyong Zou United States	12	127 0.2×	602 0.9×	166 0.3×	142 0.3×	126 0.5×	17	1.1k
Angela H. Ting United States	23	123 0.2×	1.8k 2.7×	323 0.6×	563 1.4×	418 1.8×	40	2.3k
Karl Worm Germany	22	115 0.2×	602 0.9×	305 0.5×	421 1.0×	89 0.4×	53	1.3k
Guogen Mao United States	14	150 0.2×	1.0k 1.5×	88 0.2×	479 1.2×	76 0.3×	16	1.3k
Magnus Hultdin Sweden	18	303 0.4×	509 0.7×	122 0.2×	39 0.1×	65 0.3×	41	1.4k
Chongjuan Wei United States	17	212 0.3×	516 0.7×	237 0.4×	171 0.4×	70 0.3×	34	919
Cyril Legum Israel	18	283 0.4×	354 0.5×	272 0.5×	75 0.2×	176 0.8×	58	921
Shih‐Yin Tsai United States	13	48 0.1×	1.0k 1.5×	410 0.7×	315 0.8×	74 0.3×	17	1.4k

Countries citing papers authored by Nicholas I. Fleming

Since Specialization

Citations

This map shows the geographic impact of Nicholas I. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas I. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas I. Fleming more than expected).

Fields of papers citing papers by Nicholas I. Fleming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas I. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas I. Fleming. The network helps show where Nicholas I. Fleming may publish in the future.

Co-authorship network of co-authors of Nicholas I. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas I. Fleming. A scholar is included among the top collaborators of Nicholas I. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas I. Fleming. Nicholas I. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Watson, Linley E., Yun Cao, Xiaoling Li, et al.. (2024). An IL-6 promoter variant (−174 G/C) augments IL-6 production and alters skeletal muscle transcription in response to exercise in mice. Journal of Applied Physiology. 138(1). 213–225.

Fleming, Nicholas I., et al.. (2021). SnoRNA in Cancer Progression, Metastasis and Immunotherapy Response. Biology. 10(8). 809–809. 51 indexed citations

Margolesky, Jason, et al.. (2020). Blepharoclonus in Parkinson’s Disease: a prevalent and meaningful finding? (2174). Neurology. 94(15_supplement). 2 indexed citations

Fleming, Nicholas I., et al.. (2019). Gastrointestinal Care of the Parkinson Patient. Clinics in Geriatric Medicine. 36(1). 81–92. 7 indexed citations

Campbell, Heather, Claire Vennin, Michelle Wilson, et al.. (2016). The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene. 35(38). 4981–4989. 30 indexed citations

Slatter, Tania L., Michelle Wilson, Hamish G. Campbell, et al.. (2015). Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12. OncoImmunology. 5(3). e1112941–e1112941. 13 indexed citations

Diesch, Jeannine, Elaine Sanij, Omer Gilan, et al.. (2014). Widespread FRA1-Dependent Control of Mesenchymal Transdifferentiation Programs in Colorectal Cancer Cells. PLoS ONE. 9(3). e88950–e88950. 67 indexed citations

Shalev, Idan, Terrie E. Moffitt, Antony W. Braithwaite, et al.. (2014). Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder. Molecular Psychiatry. 19(11). 1163–1170. 137 indexed citations

Fleming, Nicholas I., Kevin C. Knower, Kyren A. Lazarus, et al.. (2010). Aromatase Is a Direct Target of FOXL2: C134W in Granulosa Cell Tumors via a Single Highly Conserved Binding Site in the Ovarian Specific Promoter. PLoS ONE. 5(12). e14389–e14389. 117 indexed citations

10.

Fleming, Nicholas I., Melanie Trivett, Joshy George, et al.. (2009). Parathyroid Hormone–Related Protein Protects against Mammary Tumor Emergence and Is Associated with Monocyte Infiltration in Ductal Carcinoma In situ. Cancer Research. 69(18). 7473–7479. 29 indexed citations

11.

Ro, Seungil, Angela M. Farrelly, Nicholas I. Fleming, et al.. (2006). Template switching within exons 3 and 4 of KV11.1 (HERG) gives rise to a 5′ truncated cDNA. Biochemical and Biophysical Research Communications. 345(4). 1342–1349. 5 indexed citations

12.

Thomas, David M., Nicholas I. Fleming, Andrew J. Holloway, & David D.L. Bowtell. (2004). Molecular medicine: a clinician's primer on microarrays. Internal Medicine Journal. 34(9-10). 565–569. 1 indexed citations

13.

Tassan, Nada Al, Nikolas H. Chmiel, Julie Maynard, et al.. (2002). Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nature Genetics. 30(2). 227–232. 980 indexed citations breakdown →

14.

Cheadle, Jeremy P., Michael Krawczak, Angela Hodges, et al.. (2002). Different combinations of biallelic APC mutation confer different growth advantages in colorectal tumours.. PubMed. 62(2). 363–6. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact